| STT |
Report |
EPS (adj., 2026Q2) |
BEAT |
pred ~$3.42 vs. cons $3.28 |
HIGH |
| STT |
Report |
Total revenue (2026Q2) |
BEAT |
pred ~$3.91B vs. cons $3.862B |
MEDIUM |
| STT |
Report |
Total fee revenue (2026Q2) |
IN-LINE |
pred ~$3.06B vs. cons ~$3.04B |
MEDIUM |
| STT |
Guide |
Medium-term pretax margin target |
BETTER |
guide ~34-35% vs. cons ~31-32% (medium-term) |
MEDIUM |
| STT |
Guide |
FY26 fee revenue growth guide |
UNCHANGED |
guide ~7-9% vs. cons ~8% (FY26) |
MEDIUM |
| STT |
Guide |
Quantified AI/transformation benefit |
UNKNOWN |
guide ~qualitative/'very meaningful' vs. cons expecting hard ~$0-run-rate # (medium-term/2027) |
MEDIUM |
| STT |
Guide |
FY26 capital-return payout |
UNCHANGED |
guide ~80% vs. cons ~80% (FY26) |
MEDIUM |
| STT |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
MEDIUM |
| STT |
Return |
5-day cumulative residual |
-4.0% (FADE) |
Even with a clean EPS/revenue beat and a raised medium-term margin ceiling, the stock is at all-time highs, +83% YoY and ~30% since the Q1 print, so most positives (FX strength, SPYM/Trump Accounts, AI optimism) are priced in — a classic 'sell-the-news' setup. The Q1-level FX/Markets volatility that drove the beat is guided to moderate, so out-period estimates carry implicit cuts even after a Q2 beat; if the AI/transformation payoff is only qualitative rather than a hard number, the framework disappoints the elevated bar. Net: initial pop, if any, fades as sell-side trims forward quarters. |
MEDIUM |